US2010120914A1PendingUtilityA1

Medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis

52
Assignee: KOWA COPriority: Mar 30, 2007Filed: Mar 27, 2008Published: May 13, 2010
Est. expiryMar 30, 2027(~0.7 yrs left)· nominal 20-yr term from priority
Inventors:Yuji YoshikawaMegumi YamamotoNaoto IshibashiMami Seki
A61P 43/00A61K 31/201A61P 1/16
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis, which comprises a polyprenyl compound (e.g., 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid) as an active ingredient.

Claims

exact text as granted — not AI-modified
1 . A medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis, which comprises a polyprenyl compound as an active ingredient. 
   
   
       2 . The medicament according to  claim 1 , wherein the polyprenyl compound is a polyprenylcarboxylic acid. 
   
   
       3 . The medicament according to  claim 1 , wherein the polyprenyl compound is 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid. 
   
   
       4 . The medicament according to  claim 1 , wherein the polyprenyl compound is (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid. 
   
   
       5 . The medicament according to  claim 1 , which is in the form of a pharmaceutical composition containing a pharmacologically acceptable pharmaceutical carrier. 
   
   
       6 . The medicament according to  claim 1 , which is a preparation for oral administration. 
   
   
       7 . The medicament according to  claim 2 , which is in the form of a pharmaceutical composition containing a pharmacologically acceptable pharmaceutical carrier. 
   
   
       8 . The medicament according to  claim 3 , which is in the form of a pharmaceutical composition containing a pharmacologically acceptable pharmaceutical carrier. 
   
   
       9 . The medicament according to  claim 4 , which is in the form of a pharmaceutical composition containing a pharmacologically acceptable pharmaceutical carrier. 
   
   
       10 . The medicament according to  claim 2 , which is a preparation for oral administration. 
   
   
       11 . The medicament according to  claim 3 , which is a preparation for oral administration. 
   
   
       12 . The medicament according to  claim 4 , which is a preparation for oral administration. 
   
   
       13 . The medicament according to  claim 5 , which is a preparation for oral administration. 
   
   
       14 . The medicament according to  claim 7 , which is a preparation for oral administration. 
   
   
       15 . The medicament according to  claim 8 , which is a preparation for oral administration. 
   
   
       16 . The medicament according to  claim 9 , which is a preparation for oral administration.

Join the waitlist — get patent alerts

Track US2010120914A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.